Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Kamada Ltd. Director's Dealing 2026

Mar 22, 2026

6874_rns_2026-03-22_fb952e1f-a981-435b-9b34-51c187997538.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

E

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934

or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person Tsur David 2. Date of Event Requiring Statement (Month/Day/Year) 03/16/2026 3. Issuer Name and Ticker or Trading Symbol KAMADA LTD [ KMDA ]
(Last) (First) (Middle) 16 LERER ST. 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) ☑ Director 10% Owner Officer Other (give title below) (specify below) 5. If Amendment, Date of Original Filed (Month/Day/Year)
(Street) NESS-ZIONA L3 7404984 6. Individual or Joint/Group Filing (Check Applicable Line) ☑ Form filed by One Reporting Person ☑ Form filed by More than One Reporting Person
Table I – Non-Derivative Securities Beneficially Owned
--- --- --- --- ---
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares 607,929 D
Table II – Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
--- --- --- --- ---
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)
Date Exercisable Expiration Date Title Amount or Number of Shares
Options to purchase Ordinary Shares(1) 03/25/2021 09/25/2026 Ordinary Shares 6,625
Options to purchase Ordinary Shares(1) 03/25/2022 09/25/2026 Ordinary Shares 6,625
Options to purchase Ordinary Shares(1) 03/25/2023 09/25/2026 Ordinary Shares 6,625
Options to purchase Ordinary Shares(1) 12/22/2023 06/22/2029 Ordinary Shares 7,500
Options to purchase Ordinary Shares(1) 03/25/2024 09/25/2026 Ordinary Shares 6,625
Options to purchase Ordinary Shares(1) 12/22/2024 06/22/2029 Ordinary Shares 7,500
Options to purchase Ordinary Shares(1) 12/22/2025 06/22/2029 Ordinary Shares 7,500
Options to purchase Ordinary Shares(1) 12/22/2026 06/22/2029 Ordinary Shares 7,500

Explanation of Responses:

  1. These options to purchase ordinary shares are exercisable using a net-exercise method.
  2. All exercise prices presented in U.S. dollars represent a convenience translation from NIS based on the representative exchange rate of the Bank of Israel as of March 13, 2026.

/s/ David Tsur

03/16/2026

** Signature of Reporting Person

Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

  • If the form is filed by more than one reporting person, see Instruction 5(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.